WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line

In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients co...

Full description

Saved in:
Bibliographic Details
Published inImmunopharmacology and immunotoxicology Vol. 34; no. 1; pp. 56 - 65
Main Authors Lee, Haeyong, Bae, Sungmin, Choi, Byoung Whui, Yoon, Yoosik
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.02.2012
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0892-3973
1532-2513
1532-2513
DOI10.3109/08923973.2011.574704

Cover

Loading…
Abstract In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.
AbstractList In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.
In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/β-catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/β-catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/β-catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3β and accumulation of β-catenin protein. It was found that β-catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in β-catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor-κB (NF-κB) activity was also significantly increased in β-catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that β-catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.
In the present study, we investigated the possibility that the WNT/ beta -catenin pathway plays a role in inflammatory responses both in an human inflammatory condition and in an in vitro inflammation model. First, we analyzed gene expression patterns of the peripheral blood cells from asthma patients compared with those from normal subjects using microarray analyses. We found that intracellular signaling molecules of the WNT/ beta -catenin pathway were significantly changed in asthma patients compared with the levels in the controls. Next, we determined whether major components of the WNT/ beta -catenin pathway were involved in the lipopolysaccharide (LPS)-induced inflammatory response of the RAW264.7 macrophage cell line. Among the members of WNT/ beta -catenin pathway, the protein levels of low-density lipoprotein receptor-related protein (LRP) 6, dishevelled (DVL) 2, and AXIN1, which were measured using western blotting, did not significantly change in the presence of LPS. In contrast, the LPS induced a rapid phosphorylation of glycogen synthase kinase (GSK) 3 beta and accumulation of beta -catenin protein. It was found that beta -catenin plays a significant role in the LPS-induced inflammatory response through the performance of small interfering RNA (siRNA) transfection experiments. The mRNA level of IL-6 was significantly elevated in beta -catenin siRNA-transfected cells compared with that in control siRNA-transfected cells after LPS treatment. Furthermore, nuclear factor- Kappa B (NF- Kappa B) activity was also significantly increased in beta -catenin siRNA-transfected cells compared with the level seen in control siRNA-transfected cells. Taken together, these results suggest that beta -catenin plays a role as a negative regulator, preventing the overproduction of inflammatory cytokines such as IL-6 in LPS-induced inflammatory responses.
Author Lee, Haeyong
Yoon, Yoosik
Bae, Sungmin
Choi, Byoung Whui
Author_xml – sequence: 1
  givenname: Haeyong
  surname: Lee
  fullname: Lee, Haeyong
  email: thanks@cau.ac.kr, thanks@cau.ac.kr
  organization: Department of Microbiology, Chung-Ang University College of Medicine
– sequence: 2
  givenname: Sungmin
  surname: Bae
  fullname: Bae, Sungmin
  email: thanks@cau.ac.kr, thanks@cau.ac.kr
  organization: Department of Microbiology, Chung-Ang University College of Medicine
– sequence: 3
  givenname: Byoung Whui
  surname: Choi
  fullname: Choi, Byoung Whui
  email: thanks@cau.ac.kr, thanks@cau.ac.kr
  organization: Division of Pulmonary and Allergy Disease, Department of Internal Medicine, Chung-Ang University College of Medicine
– sequence: 4
  givenname: Yoosik
  surname: Yoon
  fullname: Yoon, Yoosik
  email: thanks@cau.ac.kr, thanks@cau.ac.kr
  organization: Department of Microbiology, Chung-Ang University College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21699440$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAURS1URKctf4BQdqwytR3HiVmAqgpopREgWtSl9cZ5aVwl9tR2VM1v8SF8E4lmigSLdmXp-dyr9-49IgfOOyTkDaPLglF1SmvFC1UVS04ZW5aVqKh4QRasLHjOS1YckMWM5DNzSI5ivKOUqYqWr8ghZ1IpIeiC3N58vT79_Ss3kNBZl20gdQ-wzWzMBt-M_TRusmkOMXUDzN8WXYoZuCZbfb_KY7LDnvpxdsOlWFbZACb4TQe3mBns-6y3Dk_Iyxb6iK_37zH5-fnT9flFvvr25fL8bJUbIVTKlZGKm7o1ooG2LpEhMi4NRS4VFgJUAxTLBrBaszWTsm2M4RUH2q6xVsCKY_Ju57sJ_n7EmPRg47wFOPRj1IrLKRQmy-dJxhkta6km8u2eHNcDNnoT7ABhqx9TnACxA6a7YwzY_kUY1XNZ-rEsPZeld2VNsvf_yYxNU8DepQC2f078cSe2rvVhgAcf-kYn2PY-tAGcsXFWP-nw4R-HDqFPnYGA-s6PwU01Pb3CH54RwFU
CitedBy_id crossref_primary_10_1155_2024_8869510
crossref_primary_10_1177_1753465813503029
crossref_primary_10_1182_blood_2015_02_622233
crossref_primary_10_4162_nrp_2015_9_1_3
crossref_primary_10_1016_j_pharmthera_2018_02_009
crossref_primary_10_1042_BSR20180548
crossref_primary_10_1007_s00011_013_0674_4
crossref_primary_10_3892_ijmm_2015_2424
crossref_primary_10_1002_jcb_24441
crossref_primary_10_1371_journal_pone_0149257
crossref_primary_10_2147_JIR_S319416
crossref_primary_10_1007_s00011_015_0891_0
crossref_primary_10_1155_2020_1061407
crossref_primary_10_1007_s10753_013_9679_y
crossref_primary_10_3727_096504016X14721731148893
crossref_primary_10_1007_s11033_016_4007_x
crossref_primary_10_1159_000507250
crossref_primary_10_1177_20587392211059362
crossref_primary_10_3727_096504013X13793555706803
crossref_primary_10_1021_acs_analchem_0c01823
crossref_primary_10_1016_j_clinbiochem_2012_05_002
crossref_primary_10_1093_intimm_dxaa002
crossref_primary_10_1007_s00436_020_07000_y
crossref_primary_10_1016_j_drudis_2017_09_001
crossref_primary_10_1038_s41598_017_08711_6
crossref_primary_10_3389_fcvm_2021_701279
crossref_primary_10_1016_j_toxlet_2020_10_002
crossref_primary_10_2147_DDDT_S344309
crossref_primary_10_1007_s00011_012_0474_2
crossref_primary_10_1186_s12964_024_01608_8
crossref_primary_10_3168_jds_2022_22983
crossref_primary_10_1038_s41467_025_56967_8
crossref_primary_10_3389_fcell_2021_641404
crossref_primary_10_1016_j_gene_2018_04_002
crossref_primary_10_1007_s12272_013_0269_1
crossref_primary_10_1016_j_intimp_2013_06_011
crossref_primary_10_1016_j_molimm_2014_02_002
crossref_primary_10_1016_j_jep_2021_114526
crossref_primary_10_1111_jcmm_12190
crossref_primary_10_1016_j_biopha_2018_02_057
crossref_primary_10_3389_fimmu_2019_01813
crossref_primary_10_1016_j_fitote_2017_10_015
crossref_primary_10_3892_mmr_2015_3632
crossref_primary_10_3892_mmr_2017_6992
crossref_primary_10_1161_ATVBAHA_118_311059
crossref_primary_10_1016_j_molimm_2019_12_013
Cites_doi 10.1073/pnas.96.10.5522
10.4049/jimmunol.167.12.6786
10.1161/STROKEAHA.107.492231
10.1016/0165-2478(94)00160-X
10.1016/S1074-7613(02)00449-1
10.1016/S0959-437X(98)80068-3
10.1182/blood.V84.9.2840.2840
10.1021/jm031101l
10.1210/jcem.87.5.8447
10.1517/14728222.11.5.613
10.1016/S0761-8425(09)73684-8
10.1016/0091-6749(92)90223-O
10.1038/sj.cdd.4401850
10.1165/ajrcmb.18.3.2972
10.1146/annurev.cellbio.14.1.59
10.3109/02770901003686472
10.1164/ajrccm/136.1.225
10.1038/18884
10.1128/MCB.13.10.6231
10.1182/blood.V89.11.4100
10.1128/MCB.10.5.2327
10.1038/labinvest.3700545
10.4049/jimmunol.164.5.2602
10.1006/geno.1994.1493
10.4049/jimmunol.174.6.3650
10.1371/journal.pone.0008979
10.1183/09031936.98.12010221
10.1002/ijc.23600
10.1002/jlb.60.1.8
10.1615/CritRevImmunol.v25.i2.10
10.2174/187152810792231904
10.1194/jlr.R800063-JLR200
10.1016/S1380-2933(97)10005-7
10.1128/MCB.10.4.1498
10.1146/annurev.cellbio.21.122303.115827
10.1146/annurev.iy.13.040195.001343
10.1371/journal.pmed.1000145
10.1046/j.1365-2249.1999.00861.x
10.1038/ng0697-161
10.4049/jimmunol.181.10.6797
10.4049/jimmunol.142.1.144
10.1073/pnas.90.21.10193
10.1074/jbc.M201304200
10.1385/CRIAI:28:3:257
10.1016/S1534-5807(03)00266-1
10.1089/ars.2006.8.1573
10.1074/jbc.M508221200
10.1111/j.1600-065X.2007.00554.x
10.1111/j.1398-9995.2006.01305.x
10.1016/0732-8893(90)90016-O
10.1074/jbc.M710396200
10.1177/1753425907088244
10.1152/ajpcell.00319.2004
10.1111/j.1365-2141.1994.tb04905.x
10.1242/jcs.02826
10.1161/ATVBAHA.107.160952
10.1111/j.1742-4658.2010.07700.x
10.1007/s11883-009-0036-4
10.1016/S0161-5890(02)00210-9
10.1242/jcs.00089
10.1159/000126450
10.1006/meth.2001.1262
10.1126/science.1071549
10.1074/jbc.M203298200
10.1152/ajpheart.00256.2001
10.4049/jimmunol.153.4.1818
10.1182/blood-2007-07-102137
10.4049/jimmunol.166.7.4713
10.1016/j.cellsig.2008.08.022
10.1067/mai.2003.169
ContentType Journal Article
Copyright 2012 Informa Healthcare USA, Inc. 2012
Copyright_xml – notice: 2012 Informa Healthcare USA, Inc. 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.3109/08923973.2011.574704
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList
MEDLINE - Academic
AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1532-2513
EndPage 65
ExternalDocumentID 21699440
10_3109_08923973_2011_574704
574704
Genre Research Article
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.GJ
00X
0BK
0R~
29I
36B
4.4
53G
5GY
5RE
5VS
AACCU
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AEYQI
AFAUU
AFKVX
AFQCT
AFWLO
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AI.
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
COF
CS3
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
JFOCU
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
MK0
O9-
QRXOQ
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UHWXJ
V1S
VH1
ZGI
~1N
ABJNI
ABLIJ
ABXYU
ACIEZ
ACUHS
ALYBC
TBQAZ
TDBHL
TERGH
TUROJ
AAGDL
AAYXX
ABWVI
ACKYO
ADYSH
AFRVT
AOYHP
CITATION
NUSFT
TASJS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
AMPGV
H94
ID FETCH-LOGICAL-c449t-9c692c8fc4daf85e1ee126c0e269e34a9da0e5dae7b1b166fdcc272a0fbe89a13
ISSN 0892-3973
1532-2513
IngestDate Fri Jul 11 01:05:00 EDT 2025
Tue Aug 05 11:12:31 EDT 2025
Mon Jul 21 05:59:34 EDT 2025
Wed Jul 16 07:19:16 EDT 2025
Thu Apr 24 22:50:18 EDT 2025
Wed Dec 25 09:04:35 EST 2024
Tue Jul 04 19:20:30 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c449t-9c692c8fc4daf85e1ee126c0e269e34a9da0e5dae7b1b166fdcc272a0fbe89a13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 21699440
PQID 912105869
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_926892165
proquest_miscellaneous_912105869
pubmed_primary_21699440
crossref_citationtrail_10_3109_08923973_2011_574704
crossref_primary_10_3109_08923973_2011_574704
informaworld_taylorfrancis_310_3109_08923973_2011_574704
informahealthcare_journals_10_3109_08923973_2011_574704
PublicationCentury 2000
PublicationDate 20120200
2/1/2012
2012-02-00
2012-Feb
20120201
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 2
  year: 2012
  text: 20120200
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Immunopharmacology and immunotoxicology
PublicationTitleAlternate Immunopharmacol Immunotoxicol
PublicationYear 2012
Publisher Informa Healthcare
Taylor & Francis
Publisher_xml – name: Informa Healthcare
– name: Taylor & Francis
References CIT0071
CIT0074
Wodarz A. (CIT0020) 1998; 14
Jirik F.R. (CIT0038) 1989; 142
Hirotani T. (CIT0041) 2005; 174
Kraus C. (CIT0017) 1994; 23
Kawahara T. (CIT0053) 2005; 288
Yachida M. (CIT0066) 1999; 116
Keshav S. (CIT0001) 1990; 13
Kim S.Y. (CIT0034) 2010; 5
Cadigan K.M. (CIT0021) 2006; 119
Akashi K. (CIT0056) 1994; 87
Duan Y. (CIT0024) 2007; 87
Diehl S. (CIT0065) 2002; 39
Pereira C.P. (CIT0044) 2009; 11
Weinbrenner A. (CIT0032) 2002; 87
Gong R. (CIT0045) 2008; 283
Kraus-Filarska M. (CIT0052) 1998; 8
Paine R. (CIT0003) 2000; 164
Huelsken J. (CIT0023) 2002; 115
CIT0040
Lee J.G. (CIT0054) 2008; 20
von Asmuth E.J. (CIT0036) 1994; 5
Moon R.T. (CIT0018) 2002; 296
Romero L.I. (CIT0037) 1993; 57
Guha M. (CIT0039) 2002; 277
Livak K.J. (CIT0033) 2001; 25
Monick M.M. (CIT0026) 2001; 166
Larché M. (CIT0063) 2003; 111
Maggi E. (CIT0064) 1998; 3
Shibata N. (CIT0002) 2009; 50
Kim J.S. (CIT0025) 2010; 277
Hersperger R. (CIT0031) 2004; 47
CIT0008
Shapira L. (CIT0010) 1994; 153
Collart M.A. (CIT0013) 1990; 10
CIT0050
Caillaud D. (CIT0048) 2009; 26
Wright G. (CIT0012) 2002; 282
Wang Y. (CIT0035) 2008; 123
West A.P. (CIT0011) 2006; 22
Hiscott J. (CIT0014) 1993; 13
Tetsu O. (CIT0046) 1999; 398
Kawai T. (CIT0009) 2006; 13
George S.J. (CIT0043) 2008; 28
Bancroft G.J. (CIT0004) 1994; 43
Sweet M.J. (CIT0007) 1996; 60
Matsusaka T. (CIT0016) 1993; 90
Mashima R. (CIT0060) 2005; 280
Tso A.R. (CIT0073) 2007; 38
CIT0015
Ye B.H. (CIT0067) 1997; 16
Wang H. (CIT0028) 2008; 181
Osugi Y. (CIT0058) 1997; 89
Kidd P. (CIT0061) 2003; 8
Thiele A. (CIT0027) 2001; 167
Nakagawa R. (CIT0059) 2002; 17
Marini M. (CIT0051) 1992; 89
Rabe B. (CIT0069) 2008; 111
Shtutman M. (CIT0047) 1999; 96
Cline M.J. (CIT0057) 1994; 84
Trinchieri G. (CIT0005) 1995; 13
CIT0022
Crane I.J. (CIT0062) 2005; 25
Rokutan K. (CIT0055) 2006; 8
Gray S. (CIT0042) 2002; 277
Veeman M.T. (CIT0019) 2003; 5
Kuo Chou T.N. (CIT0049) 2010; 47
Rose-John S. (CIT0070) 2007; 11
Whiteley W. (CIT0072) 2009; 6
Yan Z.Q. (CIT0006) 2007; 219
CIT0029
Bousquet J. (CIT0030) 2007; 62
Chalaris A. (CIT0068) 2010
References_xml – volume: 96
  start-page: 5522
  year: 1999
  ident: CIT0047
  publication-title: Proc. Natl. Acad. Sci. U.S.A
  doi: 10.1073/pnas.96.10.5522
– year: 2010
  ident: CIT0068
  publication-title: Eur. J. Cell Biol
– volume: 167
  start-page: 6786
  year: 2001
  ident: CIT0027
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.167.12.6786
– volume: 38
  start-page: 3070
  year: 2007
  ident: CIT0073
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.107.492231
– volume: 43
  start-page: 67
  year: 1994
  ident: CIT0004
  publication-title: Immunol. Lett
  doi: 10.1016/0165-2478(94)00160-X
– volume: 17
  start-page: 677
  year: 2002
  ident: CIT0059
  publication-title: Immunity
  doi: 10.1016/S1074-7613(02)00449-1
– ident: CIT0022
  doi: 10.1016/S0959-437X(98)80068-3
– volume: 84
  start-page: 2840
  year: 1994
  ident: CIT0057
  publication-title: Blood
  doi: 10.1182/blood.V84.9.2840.2840
– volume: 47
  start-page: 4950
  year: 2004
  ident: CIT0031
  publication-title: J. Med. Chem
  doi: 10.1021/jm031101l
– volume: 87
  start-page: 2160
  year: 2002
  ident: CIT0032
  publication-title: J. Clin. Endocrinol. Metab
  doi: 10.1210/jcem.87.5.8447
– volume: 11
  start-page: 613
  year: 2007
  ident: CIT0070
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1517/14728222.11.5.613
– volume: 26
  start-page: 893
  year: 2009
  ident: CIT0048
  publication-title: Rev. Mal. Respir
  doi: 10.1016/S0761-8425(09)73684-8
– volume: 89
  start-page: 1001
  year: 1992
  ident: CIT0051
  publication-title: J. Allergy Clin. Immunol
  doi: 10.1016/0091-6749(92)90223-O
– volume: 13
  start-page: 816
  year: 2006
  ident: CIT0009
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401850
– ident: CIT0008
  doi: 10.1165/ajrcmb.18.3.2972
– volume: 14
  start-page: 59
  year: 1998
  ident: CIT0020
  publication-title: Annu. Rev. Cell Dev. Biol
  doi: 10.1146/annurev.cellbio.14.1.59
– volume: 47
  start-page: 532
  year: 2010
  ident: CIT0049
  publication-title: J. Asthma
  doi: 10.3109/02770901003686472
– ident: CIT0029
  doi: 10.1164/ajrccm/136.1.225
– volume: 398
  start-page: 422
  year: 1999
  ident: CIT0046
  publication-title: Nature
  doi: 10.1038/18884
– volume: 13
  start-page: 6231
  year: 1993
  ident: CIT0014
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.13.10.6231
– volume: 5
  start-page: 301
  year: 1994
  ident: CIT0036
  publication-title: Eur. Cytokine Netw
– volume: 89
  start-page: 4100
  year: 1997
  ident: CIT0058
  publication-title: Blood
  doi: 10.1182/blood.V89.11.4100
– ident: CIT0015
  doi: 10.1128/MCB.10.5.2327
– volume: 87
  start-page: 613
  year: 2007
  ident: CIT0024
  publication-title: Lab. Invest
  doi: 10.1038/labinvest.3700545
– volume: 164
  start-page: 2602
  year: 2000
  ident: CIT0003
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.164.5.2602
– volume: 23
  start-page: 272
  year: 1994
  ident: CIT0017
  publication-title: Genomics
  doi: 10.1006/geno.1994.1493
– volume: 174
  start-page: 3650
  year: 2005
  ident: CIT0041
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.174.6.3650
– volume: 5
  start-page: e8979
  year: 2010
  ident: CIT0034
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0008979
– ident: CIT0050
  doi: 10.1183/09031936.98.12010221
– volume: 123
  start-page: 561
  year: 2008
  ident: CIT0035
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.23600
– volume: 60
  start-page: 8
  year: 1996
  ident: CIT0007
  publication-title: J. Leukoc. Biol
  doi: 10.1002/jlb.60.1.8
– volume: 25
  start-page: 75
  year: 2005
  ident: CIT0062
  publication-title: Crit. Rev. Immunol
  doi: 10.1615/CritRevImmunol.v25.i2.10
– ident: CIT0074
  doi: 10.2174/187152810792231904
– volume: 50
  start-page: S277
  year: 2009
  ident: CIT0002
  publication-title: J. Lipid Res
  doi: 10.1194/jlr.R800063-JLR200
– volume: 3
  start-page: 233
  year: 1998
  ident: CIT0064
  publication-title: Immunotechnology
  doi: 10.1016/S1380-2933(97)10005-7
– volume: 10
  start-page: 1498
  year: 1990
  ident: CIT0013
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.10.4.1498
– volume: 8
  start-page: 94
  year: 1998
  ident: CIT0052
  publication-title: J. Investig. Allergol. Clin. Immunol
– volume: 22
  start-page: 409
  year: 2006
  ident: CIT0011
  publication-title: Annu. Rev. Cell Dev. Biol
  doi: 10.1146/annurev.cellbio.21.122303.115827
– volume: 13
  start-page: 251
  year: 1995
  ident: CIT0005
  publication-title: Annu. Rev. Immunol
  doi: 10.1146/annurev.iy.13.040195.001343
– volume: 8
  start-page: 223
  year: 2003
  ident: CIT0061
  publication-title: Altern. Med. Rev
– volume: 6
  start-page: e1000145
  year: 2009
  ident: CIT0072
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000145
– volume: 116
  start-page: 140
  year: 1999
  ident: CIT0066
  publication-title: Clin. Exp. Immunol
  doi: 10.1046/j.1365-2249.1999.00861.x
– volume: 16
  start-page: 161
  year: 1997
  ident: CIT0067
  publication-title: Nat. Genet
  doi: 10.1038/ng0697-161
– volume: 181
  start-page: 6797
  year: 2008
  ident: CIT0028
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.181.10.6797
– volume: 142
  start-page: 144
  year: 1989
  ident: CIT0038
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.142.1.144
– volume: 90
  start-page: 10193
  year: 1993
  ident: CIT0016
  publication-title: Proc. Natl. Acad. Sci. U.S.A
  doi: 10.1073/pnas.90.21.10193
– volume: 277
  start-page: 34322
  year: 2002
  ident: CIT0042
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M201304200
– ident: CIT0071
  doi: 10.1385/CRIAI:28:3:257
– volume: 5
  start-page: 367
  year: 2003
  ident: CIT0019
  publication-title: Dev. Cell
  doi: 10.1016/S1534-5807(03)00266-1
– volume: 8
  start-page: 1573
  year: 2006
  ident: CIT0055
  publication-title: Antioxid. Redox Signal
  doi: 10.1089/ars.2006.8.1573
– volume: 280
  start-page: 41289
  year: 2005
  ident: CIT0060
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M508221200
– volume: 219
  start-page: 187
  year: 2007
  ident: CIT0006
  publication-title: Immunol. Rev
  doi: 10.1111/j.1600-065X.2007.00554.x
– volume: 62
  start-page: 102
  year: 2007
  ident: CIT0030
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2006.01305.x
– volume: 13
  start-page: 439
  year: 1990
  ident: CIT0001
  publication-title: Diagn. Microbiol. Infect. Dis
  doi: 10.1016/0732-8893(90)90016-O
– volume: 283
  start-page: 7401
  year: 2008
  ident: CIT0045
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M710396200
– ident: CIT0040
  doi: 10.1177/1753425907088244
– volume: 288
  start-page: C450
  year: 2005
  ident: CIT0053
  publication-title: Am. J. Physiol., Cell Physiol
  doi: 10.1152/ajpcell.00319.2004
– volume: 87
  start-page: 243
  year: 1994
  ident: CIT0056
  publication-title: Br. J. Haematol
  doi: 10.1111/j.1365-2141.1994.tb04905.x
– volume: 119
  start-page: 395
  year: 2006
  ident: CIT0021
  publication-title: J. Cell. Sci
  doi: 10.1242/jcs.02826
– volume: 28
  start-page: 400
  year: 2008
  ident: CIT0043
  publication-title: Arterioscler. Thromb. Vasc. Biol
  doi: 10.1161/ATVBAHA.107.160952
– volume: 277
  start-page: 2830
  year: 2010
  ident: CIT0025
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2010.07700.x
– volume: 11
  start-page: 236
  year: 2009
  ident: CIT0044
  publication-title: Curr. Atheroscler. Rep
  doi: 10.1007/s11883-009-0036-4
– volume: 39
  start-page: 531
  year: 2002
  ident: CIT0065
  publication-title: Mol. Immunol
  doi: 10.1016/S0161-5890(02)00210-9
– volume: 115
  start-page: 3977
  year: 2002
  ident: CIT0023
  publication-title: J. Cell. Sci
  doi: 10.1242/jcs.00089
– volume: 57
  start-page: 892
  year: 1993
  ident: CIT0037
  publication-title: Neuroendocrinology
  doi: 10.1159/000126450
– volume: 25
  start-page: 402
  year: 2001
  ident: CIT0033
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 296
  start-page: 1644
  year: 2002
  ident: CIT0018
  publication-title: Science
  doi: 10.1126/science.1071549
– volume: 277
  start-page: 32124
  year: 2002
  ident: CIT0039
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M203298200
– volume: 282
  start-page: H872
  year: 2002
  ident: CIT0012
  publication-title: Am. J. Physiol. Heart Circ. Physiol
  doi: 10.1152/ajpheart.00256.2001
– volume: 153
  start-page: 1818
  year: 1994
  ident: CIT0010
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.153.4.1818
– volume: 111
  start-page: 1021
  year: 2008
  ident: CIT0069
  publication-title: Blood
  doi: 10.1182/blood-2007-07-102137
– volume: 166
  start-page: 4713
  year: 2001
  ident: CIT0026
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.166.7.4713
– volume: 20
  start-page: 2266
  year: 2008
  ident: CIT0054
  publication-title: Cell. Signal
  doi: 10.1016/j.cellsig.2008.08.022
– volume: 111
  year: 2003
  ident: CIT0063
  publication-title: J. Allergy Clin. Immunol
  doi: 10.1067/mai.2003.169
SSID ssj0019705
Score 2.1277382
Snippet In the present study, we investigated the possibility that the WNT/β-catenin pathway plays a role in inflammatory responses both in an human inflammatory...
In the present study, we investigated the possibility that the WNT/ beta -catenin pathway plays a role in inflammatory responses both in an human inflammatory...
SourceID proquest
pubmed
crossref
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 56
SubjectTerms Adaptor Proteins, Signal Transducing - immunology
Adaptor Proteins, Signal Transducing - metabolism
Animals
Asthma - immunology
Asthma - metabolism
Asthma - pathology
Axin Protein - immunology
Axin Protein - metabolism
beta Catenin - immunology
beta Catenin - metabolism
Cell Line
cytokine
Dishevelled Proteins
Female
Glycogen Synthase Kinase 3 - immunology
Glycogen Synthase Kinase 3 - metabolism
Glycogen Synthase Kinase 3 beta
Humans
hyperactivation
IL-6
Inflammation
Interleukin-6 - immunology
Interleukin-6 - metabolism
Lipopolysaccharides - pharmacology
Low Density Lipoprotein Receptor-Related Protein-6 - immunology
Low Density Lipoprotein Receptor-Related Protein-6 - metabolism
Male
Mice
NF-kappa B - immunology
NF-kappa B - metabolism
NF-κB
Phosphoproteins - immunology
Phosphoproteins - metabolism
Wnt Proteins - immunology
Wnt Proteins - metabolism
Wnt Signaling Pathway - drug effects
Wnt Signaling Pathway - immunology
Title WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line
URI https://www.tandfonline.com/doi/abs/10.3109/08923973.2011.574704
https://www.ncbi.nlm.nih.gov/pubmed/21699440
https://www.proquest.com/docview/912105869
https://www.proquest.com/docview/926892165
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6F9MIFlXd4aQ-0l9StvX7uMQmtAoKqglTpzVrb6zhqkyDsCMLPQvwOfhMz2bXjhJJCL060ml3Lns_j2fHMN4S89lJug-HzDCsV0nDcmBk8MW2D-6nJfVPaTGJA_8Op1z933l24F43Gz1rW0ryIDuPv19aV3EarMAZ6xSrZ_9BstSgMwH_QLxxBw3D8Jx0PTwcwea93vNdlBqY2aabU7KtYYKfyySzB7lwS-ZXaIi-yiSiJVBU18_uzTwY84xMt9bEzBM_l0G9PBHb2yjCfByP77avy67t2Y99iVQkKlLTXmsVpOVzMvo3jtWi9zvbpCyyXGa2CpzovaDqajCuM9rLZMsGgu0A71B5m8_HKMqkUAfjNx5f1eAUmfqzlfqxXWWF6W93icWaAg6QsniwtMjPACbPrJlvHP-vQVPbX9WpvctWEYvMdYSuKVTwXnkqxuLqwq1JtkDfYt2GPhBPCUjxE8VCJ3yE7DDYnrEl2Ot033ZPq6xWAfJk6W16OKtnEdY6uO-2aS7SrCXOz6v5skOj-fSu0dIkGu-Se3svQjgLmfdKQ0wdk_0yhYnFAB6vavvyA7tOzGl4ekhGg9-jXjxK3VOOWjnNa4ZbCuMItLXFLAWh0Hbe0xC1d4ZYibini9hE5Pzke9PqGbvthxI7DC4PHHmdxkMZOItLAlZaUFvNiUzKPS9sRPBGmdBMh_ciKLM9LkzhmPhNmGsmAC8t-TJrT2VQ-JTTwHSGkSGE11wFjFQRpYkYiStLINrkULWKXdz6MNSc-tma5CrfpvUWMatZnxQlzg7z_h1JDbUbyG2YGddWHxTKKl6qWOzht21RawiSENwbedDGVs3kecuQMdAOPbxFhHixpeW6LPFEIqy4URjl3HPPZrS_qObm7sgsvSLP4MpcvwbMvolf6QfoN0ifyZQ
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=WNT%2F%CE%B2-catenin+pathway+is+modulated+in+asthma+patients+and+LPS-stimulated+RAW264.7+macrophage+cell+line&rft.jtitle=Immunopharmacology+and+immunotoxicology&rft.au=Lee%2C+Haeyong&rft.au=Bae%2C+Sungmin&rft.au=Choi%2C+Byoung+Whui&rft.au=Yoon%2C+Yoosik&rft.date=2012-02-01&rft.pub=Informa+Healthcare&rft.issn=0892-3973&rft.eissn=1532-2513&rft.volume=34&rft.issue=1&rft.spage=56&rft.epage=65&rft_id=info:doi/10.3109%2F08923973.2011.574704&rft.externalDocID=10_3109_08923973_2011_574704
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-3973&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-3973&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-3973&client=summon